Literature DB >> 23959786

Pre-pregnancy overweight overtakes gestational diabetes as a risk factor for subsequent metabolic syndrome.

H Ijäs1, L Morin-Papunen, A K Keränen, R Bloigu, A Ruokonen, K Puukka, T Ebeling, T Raudaskoski, M Vääräsmäki.   

Abstract

OBJECTIVE: Gestational diabetes mellitus (GDM) is associated with an increased risk of subsequent diabetes and metabolic syndrome (MS). The independent significance of overweight, often associated with GDM, is controversial. This study was aimed to investigate the prevalence of MS and carotid intima-media thickness (CIMT) values in normal and overweight women with previous insulin-treated GDM and control without GDM 19 years after the index pregnancy.
METHODS: The study group consisted of 61 women with prior GDM and 55 controls who gave birth in Oulu University Hospital between 1988 and 1993. These women were further divided into subgroups according to pre-pregnancy BMI (<25 or ≥25 kg/m(2)). In 2008-2010, anthropometrics and blood pressure were measured, blood samples were taken, and an oral glucose tolerance test was performed to investigate the components of MS. CIMT was measured by Doppler ultrasound.
RESULTS: Total prevalence of MS was 62% in the GDM group and 31% in the control group (P=0.001); it was highest (86%) in GDM women with pre-pregnancy overweight. CIMT was significantly thicker (0.67 vs 0.56 mm, P=0.007) and more often abnormal (71.7 vs 45.3%, P=0.004) in the GDM group compared with the controls. In logistic regression analysis, the strongest factor predicting MS in the whole study population was pre-pregnancy overweight.
CONCLUSIONS: Pre-pregnancy overweight was the strongest predictive factor for later MS, whereas GDM indicated increased risk of subsequent diabetes and subclinical atherosclerosis. The risk of MS was highest when both of these factors were present.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23959786     DOI: 10.1530/EJE-13-0412

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  8 in total

Review 1.  Is it worth treating gestational diabetes: if so, when and how?

Authors:  Marja Vääräsmäki
Journal:  Diabetologia       Date:  2016-05-11       Impact factor: 10.122

2.  Association between metabolic syndrome and gestational diabetes mellitus in women and their children: a systematic review and meta-analysis.

Authors:  Maleesa M Pathirana; Zohra S Lassi; Anna Ali; Margaret A Arstall; Claire T Roberts; Prabha H Andraweera
Journal:  Endocrine       Date:  2020-09-15       Impact factor: 3.633

3.  Overweight and Obesity before, during and after Pregnancy: Part 2: Evidence-based Risk Factors and Interventions.

Authors:  B Arabin; J H Stupin
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-07       Impact factor: 2.915

Review 4.  Association of gestational diabetes mellitus (GDM) with subclinical atherosclerosis: a systemic review and meta-analysis.

Authors:  Jing-Wei Li; Si-Yi He; Peng Liu; Lin Luo; Liang Zhao; Ying-Bin Xiao
Journal:  BMC Cardiovasc Disord       Date:  2014-09-29       Impact factor: 2.298

5.  An RGS2 3'UTR polymorphism is associated with preeclampsia in overweight women.

Authors:  Tiina Karppanen; Tea Kaartokallio; Miira M Klemetti; Seppo Heinonen; Eero Kajantie; Juha Kere; Katja Kivinen; Anneli Pouta; Anne Cathrine Staff; Hannele Laivuori
Journal:  BMC Genet       Date:  2016-08-24       Impact factor: 2.797

6.  Polycystic ovary syndrome and risk factors for gestational diabetes.

Authors:  Sanna Mustaniemi; Marja Vääräsmäki; Johan G Eriksson; Mika Gissler; Hannele Laivuori; Hilkka Ijäs; Aini Bloigu; Eero Kajantie; Laure Morin-Papunen
Journal:  Endocr Connect       Date:  2018-06-01       Impact factor: 3.335

7.  Estimated global overweight and obesity burden in pregnant women based on panel data model.

Authors:  Cheng Chen; Xianglong Xu; Yan Yan
Journal:  PLoS One       Date:  2018-08-09       Impact factor: 3.240

8.  Early second trimester maternal serum markers in the prediction of gestational diabetes mellitus.

Authors:  Baihui Zhao; Xiujun Han; Qing Meng; Qiong Luo
Journal:  J Diabetes Investig       Date:  2018-01-28       Impact factor: 4.232

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.